Live from the NIH registry
Studies recruiting near Omaha right now
Top 25 of 605 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Nebraska Cancer Specialists — Omaha, Nebraska (5.9 mi)
· Sponsor: Hoffmann-La Roche
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Solid Malignancies, Hematologic Malignancies
Phase 1
Interventional 190 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: Immunome, Inc.
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Nebraska Cancer Specialists — Omaha, Nebraska (5.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Nebraska Medical Center (UNMC) — Omaha, Nebraska (5.9 mi)
· Sponsor: Lyell Immunopharma, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
University Of Nebraska Medical Center /ID# 281020 — Omaha, Nebraska (5.9 mi)
· Sponsor: AbbVie
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Emotion Management Skills, Lifestyle, Healthy
N/A
Interventional 200 participants sought
Creighton University — Omaha, Nebraska (5.9 mi)
· Sponsor: soundBrilliance LLC
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Alegent Health Immanuel Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
University of Nebraska — Omaha, Nebraska (5.9 mi)
· Sponsor: GT Medical Technologies, Inc.
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Nebraska Medicine-Village Pointe — Omaha, Nebraska (5.9 mi)
· Sponsor: NRG Oncology
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Nebraska Medicine-Village Pointe — Omaha, Nebraska (5.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10018, Omaha, NE — Omaha, Nebraska (5.9 mi)
· Sponsor: Colorado Prevention Center
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Phase 3
Interventional 136 participants sought
Nebraska Methodist Hospital — Omaha, Nebraska (5.9 mi)
· Sponsor: Servier Bio-Innovation LLC
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Delirium
Phase 3
Interventional 1,800 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: Massachusetts General Hospital
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Omaha, Nebraska (5.9 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Methodist Physicians Clinic Heart Consultants — Omaha, Nebraska (5.9 mi)
· Sponsor: Duke University
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: Immuneering Corporation
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Alegent Health Immanuel Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: SWOG Cancer Research Network
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Children's Omaha — Omaha, Nebraska (5.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Omaha, Nebraska (5.9 mi)
· Sponsor: Alkermes, Inc.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Alegent Health Immanuel Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Omaha, Nebraska (5.9 mi)
· Sponsor: AstraZeneca
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0131) — Omaha, Nebraska (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi)
· Sponsor: C4 Therapeutics, Inc.
Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance
Motor Function
N/A
Interventional 10 participants sought
University of Nebraska at Omaha - Biomechanics Research Building — Omaha, Nebraska (5.9 mi)
· Sponsor: University of Nebraska